Corrigendum

This article refers to:

Retraction: Inhibition of CTCF-Regulated miRNA-185-5p Mitigates Renal Interstitial Fibrosis of Chronic Kidney Disease

In the article: Sarno MA, Mancari R, Azim Jr HA, Colombo N, Peccatori FA. Are monoclonal antibodies a safe treatment for cancer during pregnancy? Immunotherapy 5(7), 733–741 (2013) (http://www.tandfonline.com/doi/pdf/10.2217/imt.13.64), it has come to our attention that the heading of the fifth column of Table 1 was incorrectly shown as:

Table 1. Obstetrical and neonatal outcome in pregnant patients exposed to bevacizumab.

Study (year)	Number of patients	Age at pregnancy (years)	Setting	Exposure to trastuzumab	Concomitant/sequential therapies	Obstetrical complications	Delivery	Neonatal outcome	Ref.

The correct heading is:

Table 1. Obstetrical and neonatal outcome in pregnant patients exposed to bevacizumab.

Study (year)	Number of patients	Age at pregnancy (years)	Setting	Exposure to bevacizumab	Concomitant/sequential therapies	Obstetrical complications	Delivery	Neonatal outcome	Ref.

The authors and editors of Immunotherapy would like to sincerely apologize for any confusion or inconvenience caused.